Revelstoke Capital Partners said Oct. 23 that Eric A. Shuey has joined as a managing director. Shuey will be responsible for new investment sourcing, transaction execution and post-investment monitoring and oversight. Shuey previously served as a senior executive at Fresenius Medical Care.
Denver, CO (October 23, 2017) – Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, today announced it has expanded its senior investment team with the addition of Eric A. Shuey as Managing Director. Mr. Shuey will be responsible for new investment sourcing, transaction execution and post-investment monitoring and oversight.
“We are very excited to have Eric join Revelstoke as a Managing Director. He has the rare blend of a strong track record in both direct investing and successfully managing and operating businesses. We look forward to him delivering that expertise and judgement to our existing and future portfolio of companies,” said Simon Bachleda, Managing Partner at Revelstoke.
Russell Cassella, Managing Partner at Revelstoke, said, “I’ve been fortunate to have had the opportunity to work with and invest alongside Eric across numerous companies over the last decade, and I look forward to working closely with Eric to build value in our existing portfolio companies and identify new and exciting investment opportunities.”
Eric A. Shuey has more than 25 years of private equity investing, corporate finance and executive management experience in the healthcare industry. Mr. Shuey previously served as a senior executive at Fresenius Medical Care where he was involved with several major strategic initiatives including $1.5 billion of corporate investments and acquisitions. Prior to Fresenius, Mr. Shuey was a key member of the senior management team of Liberty Dialysis Holdings, Inc. which grew Liberty from a $10 million revenue business into the third largest national provider of dialysis services with over $1.0 billion of revenue and operating more than 260 clinics in 32 states. Liberty was sold to Fresenius Medical Care in early 2012 for over $2.3 billion.
Mr. Shuey has been an active investor, founder and board member of healthcare services businesses across the dialysis, bundled payment, hospitalist, cardiology, ambulatory surgery center, SaaS based healthcare business analytics, healthcare IT and contract physical therapy sectors. Earlier in his career, Mr. Shuey served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm. Mr. Shuey started his investment banking career as an associate in DLJ’s Los Angeles office.
Mr. Shuey earned an MBA from the Wharton School of Business, where he was a Palmer Scholar. In addition, he has completed the coursework for a Ph.D. in Management at the Wharton School and earned his BA from California State University, Fullerton with highest honors.
Eric Shuey added, “I am thrilled to have the opportunity to join Revelstoke Capital Partners. Revelstoke has established itself as a leading healthcare and business services private equity firm, and I am looking forward to being a key contributor to the firm’s future growth.”
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies in the healthcare and business services sectors. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition growth strategy to build exceptional companies. Revelstoke has approximately $1.0 billion of assets under management and since the firm’s inception in mid-2013 has completed 34 acquisitions, which includes 9 platform companies and 25 add-on acquisitions.